MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This Phase III clinical trial will examine the efficacy, safety, and tolerability of the
addition of MK-0431/ONO-5435 to Japanese patients with Type 2 Diabetes Mellitus who have
inadequate glycemic control on diet/exercise therapy and insulin monotherapy.